Ballot, E.; Ladoire, S.; Routy, B.; Truntzer, C.; Ghiringhelli, F.
Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy. Cancers 2020, 12, 2418.
https://doi.org/10.3390/cancers12092418
AMA Style
Ballot E, Ladoire S, Routy B, Truntzer C, Ghiringhelli F.
Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy. Cancers. 2020; 12(9):2418.
https://doi.org/10.3390/cancers12092418
Chicago/Turabian Style
Ballot, Elise, Sylvain Ladoire, Bertrand Routy, Caroline Truntzer, and François Ghiringhelli.
2020. "Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy" Cancers 12, no. 9: 2418.
https://doi.org/10.3390/cancers12092418
APA Style
Ballot, E., Ladoire, S., Routy, B., Truntzer, C., & Ghiringhelli, F.
(2020). Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy. Cancers, 12(9), 2418.
https://doi.org/10.3390/cancers12092418